Clinical trials
Observational Anemia, Refractory, with Excess of Blasts trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Not yet recruiting | 2 |
| Terminated | 2 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of California, San Francisco | 3 |
| ARCE Therapeutics, Inc. | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Beth Israel Medical Center | 1 |
| CareDx | 1 |
| Center for International Blood and Marrow Transplant Research | 1 |
| Children's Oncology Group | 1 |
| Duke University | 1 |
| Miltenyi Biomedicine GmbH | 1 |
| Skyline Diagnostics BV | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory, with Excess of Blasts | 12 |
| Leukemia, Myeloid, Acute | 7 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Anemia, Aplastic | 2 |
| Hematologic Neoplasms | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma | 2 |
| Multiple Myeloma | 2 |
| Anemia, Refractory | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.